Medicaid coverage
New Hampshire: what Medicaid covers
New Hampshire stopped covering GLP-1s prescribed solely for weight loss on January 1, 2026. The state told providers the drugs stay covered as part of a treatment plan for type 2 diabetes, cardiovascular events, severe sleep apnea or MASH.
| Drug | Position | Criteria |
|---|---|---|
| Semaglutide | Other indications only | Not covered when prescribed solely for weight loss. Cardiovascular events and MASH continue Changed January 1, 2026 |
| Tirzepatide | Other indications only | Not covered when prescribed solely for weight loss. Severe obstructive sleep apnea continues Changed January 1, 2026 |
| Liraglutide | Not covered | Named in the notice. Weight management is its only approved use, so no other-indication route remains Changed January 1, 2026 |
-
Semaglutide Other indications only
Not covered when prescribed solely for weight loss. Cardiovascular events and MASH continue
Changed January 1, 2026
-
Tirzepatide Other indications only
Not covered when prescribed solely for weight loss. Severe obstructive sleep apnea continues
Changed January 1, 2026
-
Liraglutide Not covered
Named in the notice. Weight management is its only approved use, so no other-indication route remains
Changed January 1, 2026
Sources
Every claim above is checked against the primary text, and the date is the day we last opened it.
-
1
Change in Medicaid Coverage for GLP-1 Medications
New Hampshire Division of Medicaid Services Primary text read and checked Checked August 25, 2026